GlassScriptPhysician profile
Joanna Dong
NPI 1801393160
$3,456.49
in general payments reported to CMS, 2019-2025
22 companies · $119 in 2025
The $119 reported for 2025 was less than what a typical Dermatology provider received nationally (typical 2025 total: $772).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $499 · 2020: $342 · 2021: $546 · 2022: $843 · 2023: $634 · 2024: $474 · 2025: $119.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,227.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,227.39 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $754.41 | 2020-2025 | Rinvoq, Skyrizi |
| Sun Pharmaceutical Industries INC. | $640.17 | 2021-2025 | Ilumya, Blu-U, Odomzo |
| Regeneron Healthcare Solutions, INC. | $366.77 | 2019-2022 | |
| Galderma Laboratories, L.P. | $308.69 | 2021-2022 | |
| Kerecis Limited | $203.84 | 2023-2025 | Kerecis Omega3 Marigen, Kerecis Omega3 Surgiclose, Kerecis Omega3 Graftguide |
| Genzyme Corporation | $179.15 | 2020-2021 | |
| Allergan, INC. | $149.63 | 2019 | |
| Celgene Corporation | $137.34 | 2019 | |
| Novartis Pharmaceuticals Corporation | $127.04 | 2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $109.65 | 2023 | Spevigo |
| Organogenesis INC. | $87.38 | 2023-2024 | Puraply |
| Lilly USA, LLC | $63.09 | 2022-2023 | Taltz, Olumiant |
| Ucb, INC. | $62.04 | 2022-2025 | Bimzelx |
| Incyte Corporation | $55.31 | 2022-2025 | Opzelura |
| Pfizer INC. | $40.28 | 2020-2021 |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Convatec INC. | $32.65 | 2024 | |
| Almirall LLC | $32.22 | 2023-2024 | Klisyri |
| Acera Surgical, INC. | $28.75 | 2022 | |
| Merz North America, INC. | $25.97 | 2022 | |
| Solta Medical, A Division of Bausch Health US, LLC | $21.16 | 2024 | Fraxel |
| Biofrontera INC. | $17.51 | 2022 | |
| Genentech USA, INC. | $13.44 | 2023 | Erivedge |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Joanna Dong listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.